Basic Information
| RNALocate ID: | RLID:11001643 |
| RNA Symbol: | hsa-let-7i-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-let-7i-5p |
| RNA ID: | miRBase:MIMAT0000415 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23382797 |
| Tissue/Cell Line: | Brain tissue |
| Method: | Microarray |
| Description: | We performed miRNA expression analysis using a FlexMAP3D instrument by (Luminex Corporation, Austin, TX) and a manufacturer's assay for 312 miRNA (Table S1). Data are collected from Table S1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001705 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001706 | Cytoplasm | HeLa cells | 22058130 |
| RLID:01001707 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001708 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001709 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001710 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001711 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001712 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001713 | Nucleus | HeLa cells | 22058130 |
| RLID:11001639 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
| RLID:11001640 | Exosome | Hetastatic gastric cancer cell line (AZ-P7a) | 20949044 |
| RLID:11001641 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11001642 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11001644 | Exosome | Plasma | 23663360 |
| RLID:11001645 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001646 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
| RLID:11001647 | Microvesicle | Plasma | 23077538 |
| RLID:11001648 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001649 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000069 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000343 | Microvesicle | Blood|Breast cell line|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-let-7i-5p | Oral squamous cell carcinoma | MNDR-E-MI-02201 |
| MNDR | hsa-let-7i-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-02202 |
| MNDR | hsa-let-7i-5p | Lymphoma | MNDR-E-MI-02203 |
| MNDR | hsa-let-7i-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-02204 |
| MNDR | hsa-let-7i-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-02205 |
| MNDR | hsa-let-7i-5p | Her2-receptor positive breast cancer | MNDR-E-MI-02206 |
| MNDR | hsa-let-7i-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-02207 |
| MNDR | hsa-let-7i-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-02208 |
| MNDR | hsa-let-7i-5p | Prostate cancer | MNDR-E-MI-02209 |
| MNDR | hsa-let-7i-5p | Gastric cancer | MNDR-E-MI-02210 |
| MNDR | hsa-let-7i-5p | Gastric lymphoma | MNDR-E-MI-02211 |
| MNDR | hsa-let-7i-5p | Alzheimer disease | MNDR-E-MI-02212 |
| MNDR | hsa-let-7i-5p | Malaria | MNDR-E-MI-02213 |
| MNDR | hsa-let-7i-5p | Leukemia | MNDR-E-MI-02214 |
| MNDR | hsa-let-7i-5p | Cardiovascular disease | MNDR-E-MI-02215 |
| MNDR | hsa-let-7i-5p | Carotid stenosis | MNDR-E-MI-02216 |
| MNDR | hsa-let-7i-5p | Lung cancer | MNDR-E-MI-02217 |
| MNDR | hsa-let-7i-5p | Metabolic syndrome x | MNDR-E-MI-02218 |
| MNDR | hsa-let-7i-5p | Parkinson disease | MNDR-E-MI-02219 |
| MNDR | hsa-let-7i-5p | Breast cancer | MNDR-E-MI-02220 |
| MNDR | hsa-let-7i-5p | Thyroid cancer | MNDR-E-MI-02221 |
| MNDR | hsa-let-7i-5p | Pancreatic cancer | MNDR-E-MI-02222 |
| MNDR | hsa-let-7i-5p | Melanoma | MNDR-E-MI-02223 |
| MNDR | hsa-let-7i-5p | Epithelial ovarian cancer | MNDR-E-MI-02224 |
| MNDR | hsa-let-7i-5p | Nephroblastoma | MNDR-E-MI-02225 |
| MNDR | hsa-let-7i-5p | Colon cancer | MNDR-E-MI-02226 |
| MNDR | hsa-let-7i-5p | Familial ovarian cancer | MNDR-E-MI-02227 |
| MNDR | hsa-let-7i-5p | Carcinoma ductal breast | MNDR-E-MI-02228 |
| MNDR | hsa-let-7i-5p | Glioblastoma | MNDR-E-MI-02229 |
| MNDR | hsa-let-7i-5p | Glioma | MNDR-E-MI-02230 |
| MNDR | hsa-let-7i-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-02231 |
| MNDR | hsa-let-7i-5p | Chordoma | MNDR-E-MI-02232 |
| MNDR | hsa-let-7i-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-02233 |
| MNDR | hsa-let-7i-5p | Osteosarcoma | MNDR-E-MI-02234 |
| MNDR | hsa-let-7i-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-02235 |
| MNDR | hsa-let-7i-5p | Liver cancer | MNDR-E-MI-02236 |
| MNDR | hsa-let-7i-5p | Uterine cancer | MNDR-E-MI-02237 |
| MNDR | hsa-let-7i-5p | Cervical adenocarcinoma | MNDR-E-MI-02238 |
| MNDR | hsa-let-7i-5p | Gastric adenocarcinoma | MNDR-E-MI-02239 |
| MNDR | hsa-let-7i-5p | Cervical squamous cell carcinoma | MNDR-E-MI-02240 |
| MNDR | hsa-let-7i-5p | Lung squamous cell carcinoma | MNDR-E-MI-02241 |
| MNDR | hsa-let-7i-5p | Lung adenocarcinoma | MNDR-E-MI-02242 |
| MNDR | hsa-let-7i-5p | Adrenocortical cancer | MNDR-E-MI-02243 |
| MNDR | hsa-let-7i-5p | Thyroid carcinoma | MNDR-E-MI-02244 |
| MNDR | hsa-let-7i-5p | Tuberculosis | MNDR-E-MI-02245 |
| MNDR | hsa-let-7i-5p | Bladder urothelial carcinoma | MNDR-E-MI-02246 |
| MNDR | hsa-let-7i-5p | Pancreatic adenocarcinoma | MNDR-E-MI-02247 |
| MNDR | hsa-let-7i-5p | Carcinoma renal cell | MNDR-E-MI-02248 |
| MNDR | hsa-let-7i-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-02249 |
| MNDR | hsa-let-7i-5p | Clear cell renal cell carcinoma | MNDR-E-MI-02250 |
| MNDR | hsa-let-7i-5p | Biliary tract cancer | MNDR-E-MI-02251 |
| MNDR | hsa-let-7i-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-02252 |
| MNDR | hsa-let-7i-5p | Cholangiocarcinoma | MNDR-E-MI-02253 |
| MNDR | hsa-let-7i-5p | Esophageal cancer | MNDR-E-MI-02254 |
| MNDR | hsa-let-7i-5p | Liver cirrhosis | MNDR-E-MI-02255 |
| MNDR | hsa-let-7i-5p | Lung small cell carcinoma | MNDR-E-MI-02256 |
| MNDR | hsa-let-7i-5p | T acute lymphoblastic leukemia | MNDR-E-MI-02257 |
| MNDR | hsa-let-7i-5p | Acute t cell leukemia | MNDR-E-MI-02258 |
| MNDR | hsa-let-7i-5p | Fibromyalgia | MNDR-E-MI-02259 |
| MNDR | hsa-let-7i-5p | Adenoma | MNDR-E-MI-02260 |
| MNDR | hsa-let-7i-5p | Breast invasive carcinoma | MNDR-E-MI-02261 |
| MNDR | hsa-let-7i-5p | Early hepatocellular carcinoma | MNDR-E-MI-02262 |
| MNDR | hsa-let-7i-5p | Familiar ovarian carcinoma | MNDR-E-MI-02263 |
| MNDR | hsa-let-7i-5p | B-cell lymphoma | MNDR-E-MI-02264 |
| MNDR | hsa-let-7i-5p | Rheumatoid arthritis | MNDR-E-MI-02265 |
| MNDR | hsa-let-7i-5p | T-cell leukemia | MNDR-E-MI-02266 |
| MNDR | hsa-let-7i-5p | Retinoblastoma | MNDR-E-MI-02267 |
| MNDR | hsa-let-7i-5p | Neuroblastoma | MNDR-E-MI-02268 |
| MNDR | hsa-let-7i-5p | Neuromyelitis optica | MNDR-E-MI-02269 |
| MNDR | hsa-let-7i-5p | Acute myelogenous leukemia | MNDR-E-MI-02270 |
| MNDR | hsa-let-7i-5p | Colorectal cancer | MNDR-E-MI-02271 |
| MNDR | hsa-let-7i-5p | Nasopharynx carcinoma | MNDR-E-MI-02272 |
| MNDR | hsa-let-7i-5p | Multiple myeloma | MNDR-E-MI-02273 |
| MNDR | hsa-let-7i-5p | Acute lymphocytic leukemia | MNDR-E-MI-02274 |
| MNDR | hsa-let-7i-5p | Epithelial ovarian carcinoma | MNDR-E-MI-02275 |
| MNDR | hsa-let-7i-5p | Nasopharyngeal cancer | MNDR-E-MI-02276 |
| MNDR | hsa-let-7i-5p | Prostatic neoplasms | MNDR-E-MI-02277 |
| MNDR | hsa-let-7i-5p | Aldh1+ cancer stem cells | MNDR-E-MI-02278 |
| MNDR | hsa-let-7i-5p | Low grade dysplastic nodule | MNDR-E-MI-02279 |
| MNDR | hsa-let-7i-5p | Tubulovillous adenoma | MNDR-E-MI-02280 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCC10 | Homo sapiens | RR00023407 |
TOP